Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01427023 · ClinicalTrials.gov registry record

Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing

A clinical trial of Trichomonas Vaginalis, sponsored by Gen-Probe, Incorporated.

Completed
Registry status
532
Enrollment target
7
Study locations

NCT01427023 is a study of Trichomonas Vaginalis that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 532 participants. The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01427023, a study of Trichomonas Vaginalis, has completed, sponsored by Gen-Probe, Incorporated.

COMPLETED
Registry status
532 participants
Enrollment target
7
Study locations

Study Summary

The objective of this study is to obtain female first-catch urine, vaginal swab, endocervical swab, and cervical specimens collected in PreservCyt Solution ("PreservCyt Specimens") for testing with the APTIMA Trichomonas vaginalis (ATV) Assay. These specimens will be used to demonstrate assay performance on the PANTHER System is comparable to performance on the TIGRIS System.

Conditions Studied

Interventions

  • DEVICE APTIMA Trichomonas vaginalis (ATV) Assay

Study Locations (7)

Alabama

  • University of Alabama, Birmingham - Birmingham

Indiana

  • Wishard Hospital - Indiana University School of Medicine - Indianapolis

Louisiana

  • Louisiana State University - New Orleans

Massachusetts

  • New England Center for Clinical Research - Fall River

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Tennessee

  • Geneuity Clinical Research Services - Maryville

Texas

  • Planned Parenthood Gulf Coast - Houston

Trial Details

FieldValue
Enrollment Target 532 participants
Start Date 2012-08
Est. Completion 2013-12

Sponsor

Gen-Probe, Incorporated

12 total trials

What the Registry Record Tells You About NCT01427023

The ClinicalTrials.gov registry entry for NCT01427023 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trichomonas Vaginalis appearing as the primary indexed condition, and to 1 intervention - of which APTIMA Trichomonas vaginalis (ATV) Assay is the first listed.

NCT01427023 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, Indiana, Louisiana.

Frequently Asked Questions

What is clinical trial NCT01427023 about?

NCT01427023 is a clinical study titled "Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing". The objective of this study is to obtain female first-catch urine, vaginal swab, endocervical swab, and cervical specimens collected in PreservCyt Solution ("PreservCyt Specimens") for testing with the APTIMA Trichomonas vaginalis (ATV) Assay. These specimens will be used to demonstrate assay perfo...

What is the current status of trial NCT01427023?

This trial is currently completed. The enrollment target is 532 participants. The study started on 2012-08. Estimated completion is 2013-12.

What conditions does trial NCT01427023 study?

This clinical trial studies the following conditions: Trichomonas Vaginalis.

What interventions are being tested in trial NCT01427023?

The interventions under investigation include: APTIMA Trichomonas vaginalis (ATV) Assay (DEVICE).

Who is sponsoring clinical trial NCT01427023?

This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01427023 being conducted?

This trial has 7 study locations across Alabama, Indiana, Louisiana, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trichomonas Vaginalis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.